IL110161A - תולדות של 2-]1-)1,3-תיאזולין-2-איל(אזתידין-3-איל-איל[ תיוקארבאפנם, הכנתן ותכשירי רוקחות המכילים אותם - Google Patents

תולדות של 2-]1-)1,3-תיאזולין-2-איל(אזתידין-3-איל-איל[ תיוקארבאפנם, הכנתן ותכשירי רוקחות המכילים אותם

Info

Publication number
IL110161A
IL110161A IL11016194A IL11016194A IL110161A IL 110161 A IL110161 A IL 110161A IL 11016194 A IL11016194 A IL 11016194A IL 11016194 A IL11016194 A IL 11016194A IL 110161 A IL110161 A IL 110161A
Authority
IL
Israel
Prior art keywords
compound
formula
group
azetidin
thio
Prior art date
Application number
IL11016194A
Other languages
English (en)
Other versions
IL110161A0 (en
Original Assignee
Lederle Japan Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lederle Japan Ltd filed Critical Lederle Japan Ltd
Publication of IL110161A0 publication Critical patent/IL110161A0/xx
Publication of IL110161A publication Critical patent/IL110161A/he

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D477/00—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16—Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20—Sulfur atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
IL11016194A 1993-07-01 1994-06-29 תולדות של 2-]1-)1,3-תיאזולין-2-איל(אזתידין-3-איל-איל[ תיוקארבאפנם, הכנתן ותכשירי רוקחות המכילים אותם IL110161A (he)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21330693 1993-07-01
JP7932094 1994-03-28
JP12204694 1994-05-12

Publications (2)

Publication Number Publication Date
IL110161A0 IL110161A0 (en) 1994-10-07
IL110161A true IL110161A (he) 1998-09-24

Family

ID=27302982

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11016194A IL110161A (he) 1993-07-01 1994-06-29 תולדות של 2-]1-)1,3-תיאזולין-2-איל(אזתידין-3-איל-איל[ תיוקארבאפנם, הכנתן ותכשירי רוקחות המכילים אותם

Country Status (16)

Country Link
US (2) US5534510A (he)
EP (2) EP0632039B1 (he)
JP (1) JP2666118B2 (he)
KR (1) KR100331293B1 (he)
AT (2) ATE212636T1 (he)
AU (1) AU682510B2 (he)
CA (1) CA2127193C (he)
DE (2) DE69433955T2 (he)
DK (2) DK0632039T3 (he)
ES (2) ES2170080T3 (he)
FI (1) FI106962B (he)
HU (1) HU220609B1 (he)
IL (1) IL110161A (he)
NO (2) NO306780B1 (he)
PT (2) PT924210E (he)
TW (1) TW254943B (he)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5783703A (en) * 1993-07-01 1998-07-21 Lederle (Japan), Ltd. Sulfur-containing compounds method for their use and prodction
TW432061B (en) * 1994-08-09 2001-05-01 Pfizer Res & Dev Lactams
NO955007L (no) * 1994-12-12 1996-06-13 Lederle Japan Ltd Tiolforbindelser
TW420681B (en) * 1995-12-08 2001-02-01 Lederle Japan Ltd Carbapenem-3-carboxylic acid ester derivatives
NZ332687A (en) 1996-05-09 2000-05-26 Sankyo Co use of 1-methyl-carbapenem derivatives as anti-helicobacter pylori agents
KR20010079713A (ko) * 1998-09-10 2001-08-22 마쓰자와 도로, 하야시 지로 카르바페넴 화합물
KR100325375B1 (ko) * 2000-01-31 2002-03-06 박호군 이미다졸린 고리가 치환된 카바페넴 유도체
SK5982003A3 (en) * 2000-11-16 2004-05-04 Sankyo Co 1-Methylcarbapenem derivatives
KR100441406B1 (ko) * 2001-09-05 2004-07-23 한국과학기술연구원 티아졸리딘 고리 치환체를 갖는 1-β-메틸 카바페넴유도체 및 그 제조 방법
KR100451670B1 (ko) * 2001-09-14 2004-10-08 한국화학연구원 내성균에 대해 항생작용을 갖는 카바페넴 유도체 및 이의제조방법
EP1443047A4 (en) 2001-11-05 2005-04-27 Sumitomo Pharma NEW CARBAPENE COMPOUNDS
TW200403244A (en) * 2002-05-14 2004-03-01 Sankyo Co 1β-Methylcarbapenem derivatives for oral use
WO2004035540A1 (ja) 2002-10-18 2004-04-29 Meiji Seika Kaisha, Ltd. マロン酸モノエステルおよびその製造方法
AU2003301425A1 (en) * 2002-10-18 2004-05-04 Meiji Seika Kaisha, Ltd. Process for producing carbapenem derivative and intermediate for use in the production
KR101059339B1 (ko) * 2002-11-13 2011-08-24 가부시키가이샤 가네카 경구 투여용 카르바페넴 화합물의 제조 방법
JPWO2004089954A1 (ja) * 2003-04-08 2006-07-06 大日本住友製薬株式会社 新規なカルバペネム化合物
KR101188930B1 (ko) * 2003-12-30 2012-10-08 메디시스 테크놀로지스 코포레이션 가동 제어가 있는 초음파 치료 헤드
EP1627891A1 (en) * 2004-08-11 2006-02-22 Covion Organic Semiconductors GmbH Polymers for use in organic electroluminescent devices
KR100599876B1 (ko) * 2004-08-31 2006-07-13 한국화학연구원 2-아릴메틸아제티딘 카바페넴 유도체 및 그의 제조방법
EP1785426A4 (en) * 2004-09-03 2008-02-20 Dainippon Sumitomo Pharma Co NEW CARBAPENEM DERIVATIVE
JP2006176418A (ja) * 2004-12-21 2006-07-06 Kaneka Corp 経口投与用カルバペネム化合物の製造方法と新規β−ラクタム化合物
EP1864985A4 (en) * 2005-03-25 2010-01-06 Dainippon Sumitomo Pharma Co NEW CARBAPENEM COMPOUND
KR100723889B1 (ko) 2006-06-30 2007-05-31 주식회사 하이닉스반도체 직렬 입/출력 인터페이스를 가진 멀티 포트 메모리 소자
JP5013795B2 (ja) * 2006-09-25 2012-08-29 Ｍｅｉｊｉ Ｓｅｉｋａファルマ株式会社 経口投与用カルバペネム
CN101848911A (zh) * 2007-09-20 2010-09-29 国际药品工业株式会社 碳青霉烯类抗生素的合成中间体的酸加成盐及其制备方法
JP2011504495A (ja) * 2007-11-23 2011-02-10 クジェ ファーマシューティカル インダストリアル カンパニー リミテッド ２−アリールメチルアゼチジン−カルバペネム−３−カルボン酸エステル誘導体またはその塩、その製造方法及びそれを含む医薬組成物
CN102558181B (zh) * 2010-12-15 2015-04-22 石药集团中奇制药技术（石家庄）有限公司 一种碳青霉烯抗生素的制备方法
CN102731507B (zh) * 2011-04-13 2015-04-01 石药集团中奇制药技术（石家庄）有限公司 泰比培南晶型、其制备方法及其在制备药物中的应用
CN103059026A (zh) * 2011-10-20 2013-04-24 北京康健源科技有限公司 一种替比培南匹夫酯的制备方法
CN102584812B (zh) * 2011-11-18 2014-03-12 深圳万乐药业有限公司 一种泰比培南酯杂质的制备方法
CN102503940B (zh) * 2011-11-22 2013-12-25 深圳万乐药业有限公司 制备泰比培南酯开环杂质的方法
CN103059027A (zh) * 2012-12-20 2013-04-24 安徽悦康凯悦制药有限公司 替比培南匹伏酯的制备方法
CN115192533A (zh) * 2016-12-15 2022-10-18 斯派尔治疗有限公司 新型替比培南匹伏酯速释和调释口服剂型
CA3049690C (en) * 2017-02-06 2023-03-21 Spero Therapeutics, Inc. Tebipenem pivoxil crystalline forms, compositions including the same, methods of manufacture, and methods of use
CN110698469A (zh) * 2019-10-28 2020-01-17 南京红杉生物科技有限公司 泰比培南酯中间体及其合成方法、应用
AU2021378320A1 (en) 2020-11-11 2023-06-22 Spero Therapeutics, Inc. High dosage tebipenem pivoxil tablet formulation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3665001A (en) * 1970-06-11 1972-05-23 Exxon Research Engineering Co Azinyl organophosphorus compounds
JPS60202886A (ja) * 1984-03-27 1985-10-14 Sankyo Co Ltd １―置換カルバペネム―３―カルボン酸誘導体
US4696923A (en) * 1984-04-23 1987-09-29 Merck & Co., Inc. 6-[1-hydroxyethyl]-2-SR8 -1-methyl-1-carbadethiapen-2-em-3-carboxylic acids
JPS63255280A (ja) * 1987-04-11 1988-10-21 Nippon Redarii Kk （１ｒ，５ｓ，６ｓ）−２−置換−６−〔（ｒ）−１−ヒドロキシエチル〕−１−メチル−カルバペネム−３−カルボン酸誘導体
GB9210096D0 (en) * 1992-05-11 1992-06-24 Fujisawa Pharmaceutical Co 1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid derivatives and their preparation

Also Published As

Publication number Publication date
DE69433955D1 (de) 2004-09-23
EP0924210A1 (en) 1999-06-23
ATE273975T1 (de) 2004-09-15
KR100331293B1 (ko) 2002-10-25
HU220609B1 (hu) 2002-03-28
US5679790A (en) 1997-10-21
EP0924210B1 (en) 2004-08-18
TW254943B (he) 1995-08-21
IL110161A0 (en) 1994-10-07
FI106962B (fi) 2001-05-15
NO307379B1 (no) 2000-03-27
NO942483D0 (no) 1994-06-30
JP2666118B2 (ja) 1997-10-22
HUT68057A (en) 1995-05-29
PT632039E (pt) 2002-06-28
AU682510B2 (en) 1997-10-09
EP0632039B1 (en) 2002-01-30
ES2170080T3 (es) 2002-08-01
US5534510A (en) 1996-07-09
KR950003292A (ko) 1995-02-16
NO942483L (no) 1995-01-02
HU9401957D0 (en) 1994-09-28
CA2127193C (en) 2005-04-12
NO306780B1 (no) 1999-12-20
PT924210E (pt) 2004-12-31
AU6598794A (en) 1995-01-12
NO991019L (no) 1995-01-02
JPH0853453A (ja) 1996-02-27
EP0632039A1 (en) 1995-01-04
DK0924210T3 (da) 2004-12-13
ATE212636T1 (de) 2002-02-15
DK0632039T3 (da) 2002-05-13
CA2127193A1 (en) 1995-01-02
FI943164A (fi) 1995-01-02
DE69433955T2 (de) 2005-09-08
ES2222630T3 (es) 2005-02-01
DE69429742T2 (de) 2002-06-06
NO991019D0 (no) 1999-03-02
DE69429742D1 (de) 2002-03-14
FI943164A0 (fi) 1994-07-01

Similar Documents

Publication Publication Date Title
EP0632039B1 (en) 2-[1-(1,3-Thiazolin-2-yl)azetidin-3-yl]thio-carbapenem derivatives
FI84826C (fi) Foerfarande foer framstaellning av 6 -(1-hydroxietyl-2-substituerad-2-karbapenem-3-karboxylsyror anvaendbara som laekemedel.
EP0160391B1 (en) Carbapenem derivatives and compositions containing them
CZ286878B6 (en) Carbapenems, process of their preparation, intermediates for their preparation, those carbapenems used for treating infections and pharmaceutical preparations
US5153187A (en) 1-methylcarbapenem derivatives and process for preparation thereof
CA1340274C (en) (1r,5s,6s)-2-substituted thio-6-¬(r)-1-hydroxy-ethyl|-1-methyl-carbapenem-3-carboxylic acid derivatives
US5519015A (en) Carbapenem antibiotic compounds
US5783703A (en) Sulfur-containing compounds method for their use and prodction
CZ292623B6 (cs) Karbapenemové deriváty, antibakteriální činidlo s jejich obsahem a jejich meziproduktové sloučeniny
US5444057A (en) Carbapenem-antibiotic compounds
US6479478B1 (en) Carbapenem compounds
US5208348A (en) Mercaptan compound
US5527793A (en) Antibiotic carbapenem compounds
JP2003183282A (ja) カルバペネム化合物
AU604949B2 (en) (1r,5s,6s)-2-substituted thio-6-{(r)-1-hydroxyethyl}-1-methyl-carbapenem-3- carboxylic acid derivatives
JP2003183281A (ja) カルバペネム化合物
JP2003183280A (ja) カルバペネム化合物
EP0358085A1 (en) (1R,5S,6S)-6-[(R)-1-Hydroxyethyl]-1-methyl-2-[(1-alkyl-1,2,4-triazolium-2-yl)alkyl]-thio-carbapenem-3-carboxylic acid derivatives
JP2003104893A (ja) １−メチルカルバペネム化合物を含有する抗菌剤
JPH0717977A (ja) （１ｒ，５ｓ，６ｓ）−２−［（４−置換−１，３−チアゾール−２−イル）アミノカルボニルメチルチオ］−６−［（ｒ）−１−ヒドロキシエチル］−１−メチル−カルバペン−２−エム−３−カルボキシレート

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
HC Change of name of proprietor(s)
KB Patent renewed
KB Patent renewed
KB Patent renewed
EXP Patent expired